Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1

被引:84
作者
Lijnen, HR
Maquoi, E
Morange, P
Voros, G
Van Hoef, B
Kopp, F
Collen, D
Juhan-Vague, I
Alessi, MC
机构
[1] Univ Leuven, Ctr Mol & Vasc Biol, B-3000 Louvain, Belgium
[2] CHU Timone, Haematol Lab, Marseille, France
[3] INSERM, EPI 9936, F-13258 Marseille, France
[4] CHU Timone, Histol Lab, Marseille, France
关键词
plasminogen activator inhibitor-1; obesity; adipose tissue; adipocyte;
D O I
10.1161/01.ATV.0000044457.60665.DD
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-The objective of this study was to investigate the role of plasminogen activator inhibitor-1 (PAI-1) in adipose tissue development in vivo, Methods and Result-Transgenic (Tg) mice overexpressing murine PAI-1 under control of the adipocyte promoter aP2 and wild-type (WT) controls were kept on standard food (SFD) or on high-fat diet (HFD) for 15 weeks. The body weight and the weight of the isolated subcutaneous and gonadal fat deposits of the Tg mice kept on the RFD were significantly lower than those of the WT mice. The number of adipocytes in the adipose tissue was similar for Tg and WT mice on the HFD, but adipocyte hypotrophy and a significantly lower ratio of stroma cells/adipocytes were observed in the Tg mice. A significant negative correlation (P<0.01) was observed between expression of preadipocyte factor-1, which blocks adipocyte differentiation, and adipose tissue weight. Fasting insulin and total cholesterol levels on the HFD were lower in Tg than in WT mice. Conclusions-High circulating PAI-1 levels attenuate nutritionally induced obesity. This may be related to modifications in adipose tissue cellularity affecting weight and plasma metabolic parameters.
引用
收藏
页码:78 / 84
页数:7
相关论文
共 42 条
[1]   Production of plasminogen activator inhibitor 1 by human adipose tissue - Possible link between visceral fat accumulation and vascular disease [J].
Alessi, MC ;
Peiretti, F ;
Morange, P ;
Henry, M ;
Nalbone, G ;
JuhanVague, I .
DIABETES, 1997, 46 (05) :860-867
[2]   Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat - Evidence of differences between visceral and subcutaneous deposits [J].
Bastelica, D ;
Morange, P ;
Berthet, B ;
Borghi, H ;
Lacroix, O ;
Grino, M ;
Juhan-Vague, I ;
Alessi, MC .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (01) :173-178
[3]   Development and disease in proteinase-deficient mice: Role of the plasminogen, matrix metalloproteinase and coagulation system [J].
Carmeliet, P ;
Collen, D .
THROMBOSIS RESEARCH, 1998, 91 (06) :255-285
[4]   Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men [J].
Cigolini, M ;
Targher, G ;
Andreis, IAB ;
Tonoli, M ;
Agostino, G ;
DeSandre, G .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (03) :368-374
[5]   Expression of plasminogen activator inhibitor-1 in human adipose tissue:: a role for TNF-α? [J].
Cigolini, M ;
Tonoli, M ;
Borgato, L ;
Frigotto, L ;
Manzato, F ;
Zeminian, S ;
Cardinale, C ;
Camin, M ;
Chiaramonte, E ;
De Sandre, G ;
Lunardi, C .
ATHEROSCLEROSIS, 1999, 143 (01) :81-90
[6]   A review of the microcirculation of adipose tissue: Anatomic, metabolic and angiogenic perspectives [J].
Crandall, DL ;
Hausman, GJ ;
Kral, JG .
MICROCIRCULATION-LONDON, 1997, 4 (02) :211-232
[7]   Release of PAI-1 by human preadipocytes and adipocytes independent of insulin and IGF-1 [J].
Crandall, DL ;
Groeling, TM ;
Busler, DE ;
Antrilli, TM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 279 (03) :984-988
[8]  
DECLERCK PJ, 1995, THROMB HAEMOSTASIS, V74, P1305
[9]  
Eren M, 2001, ARTERIOSCL THROM VAS, V21, P695
[10]   Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals [J].
Eriksson, P ;
Reynisdottir, S ;
Lönnqvist, F ;
Stemme, V ;
Hamsten, A ;
Arner, P .
DIABETOLOGIA, 1998, 41 (01) :65-71